Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients
Abstract Background Psychological co-morbidities in irritable bowel syndrome (IBS) have been widely recognized, whereas less is known regarding the role of gut microbial and host metabolic changes in clinical and psychological symptoms in IBS. Results A total of 70 diarrhoea-predominant IBS (IBS-D)...
Main Authors: | Tong Liu, Xiang Gu, Li-Xiang Li, Ming Li, Bing Li, Xiao Cui, Xiu-li Zuo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12866-020-01841-4 |
Similar Items
-
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
by: Leighton Matthew P, et al.
Published: (2013-01-01) -
Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
by: Xianwei Lin, et al.
Published: (2019-05-01) -
Impact of symptom severity in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D): results from two separate surveys of HCPs and patients with IBS-D
by: Anton Emmanuel, et al.
Published: (2020-04-01) -
Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
by: Dwaipayan Sarathi Chakraborty, et al.
Published: (2019-01-01) -
Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study
by: Michele Linsalata, et al.
Published: (2018-11-01)